New CFTR modulators for F508del mutations? New research into reducing inflammation in the CF lung? In this issue, Dr. Jennifer Taylor-Cousar from National Jewish Health in Denver explains the potential clinical impact of new and emerging CF disease modifying therapies.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Podcast (ecystic): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS